Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Global Pharma Healthcare: Setting the global benchmark in quality, innovation, and care

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Opatanol

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 4,682Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Gland’s Generics Olopatadine HCl Receives Approval in US
    Gland’s Generics Olopatadine HCl Receives Approval in US

    06 Jan 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213514

    FDA
    06 Jan 2026
    Share Share
    Glenmark Secures China Approval For Ryaltris
    Glenmark Secures China Approval For Ryaltris

    10 Nov 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/drug-approval/glenmark-secures-china-approval-for-ryaltris-18201

    INDPHARMAPOST
    10 Nov 2025
    Share Share
    Enforcement Report - Week of October 29, 2025
    Enforcement Report - Week of October 29, 2025

    29 Oct 2025

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-29-2025-82388.pdf

    FDA
    29 Oct 2025
    Share Share
    FDC`s Generics Olopatadine Hydrochloride Receives Approval in US
    FDC`s Generics Olopatadine Hydrochloride Receives Approval in US

    14 Jul 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217051

    FDA
    14 Jul 2025
    Share Share
    Glenmark Launches Olopatadine Eye Drops in US Market
    Glenmark Launches Olopatadine Eye Drops in US Market

    16 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/glenmark-therapeutics-inc-usa-launches-olopatadine-hydrochloride-ophthalmic-solution-usp-0-2-otc-302482216.html

    PR NEWSWIRE
    16 Jun 2025
    Share Share
    Glenmark receives ANDA approval for Olopatadine ophthalmic solution
    Glenmark receives ANDA approval for Olopatadine ophthalmic solution

    21 Mar 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/drug-approval/glenmark-receives-anda-approval-for-olopatadine-hydrochloride-ophthalmic-solution-usp-02-16923

    INDPHARMAPOST
    21 Mar 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.